Dr. Neerja Agrawal, MD

Dr. Agrawal practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Agrawal's NPI, 1477500254, was assigned on May 27, 2006. Dr. Agrawal holds Florida license ME117607.

Dr. Agrawal's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Agrawal's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Agrawal is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Agrawal to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Agrawal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Agrawal's licenses on file in 6 states: Florida, Pennsylvania, Iowa, Illinois, Massachusetts and Connecticut.

CMS data shows 691 Medicare services from Dr. Agrawal across 5 procedure codes in 2024, for 195 Medicare patients. Medicare paid $72,074 for them.

CMS counts 195 Medicare patients who saw Dr. Agrawal in 2024. The largest group is under 65, with 108 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 5.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 58, with 38% women.

In 2024, Dr. Agrawal wrote 911 Medicare Part D claims for 214 patients. 95% of them were for generic drugs. CMS names the drug for 749 of them, across 19 drugs with 11 or more claims each, at $21,770 in total drug cost. In 2023, CMS named 285 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Agrawal for performance year 2024, reported through an alternative payment model (APM). Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agrawal as offering telehealth.

Dmand AI links 4 papers to Dr. Agrawal, published from 2016 to 2022. The most frequent topics are Kidney. Dr. Agrawal's most frequent co-authors are Ignacio Alfonso Echenique, MD, Basit Javaid, MD and Pradeep Vasudeva Kadambi, MBA, MD.

Dmand AI links Dr. Agrawal to 2 clinical trials. 2 are still active or recruiting.

CMS Open Payments shows 14 general payments to Dr. Agrawal from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 88% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $351.

Dr. Agrawal is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.